Still taking advantage of the fact that competitor Philips’ respiratory care business remains stanched by its ongoing CPAP machine recall, ResMed continues to carve out an even bigger foothold for ...
As competitor Philips continues to grapple with the effects of its long-standing recall of continuous positive airway pressure (CPAP) machines and other respiratory devices, ResMed is now issuing a ...
The Philips respiratory machine recall is a no-win situation for patients and doctors. But for the medical device giant’s longtime rivals and new competitors, business is looking up. “We think it will ...
ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business model. I rate RMD a strong sell due to the imminent threat from Apnimed's ...
ResMed’s mission, according to its website, is to ‘provide life-changing diagnoses and treatments to patients with sleep apnea’. Apnimed says patients deserve more – a ‘simple, safe and effective ...
The Oura Ring worn while sleeping [Image courtesy of Oura] Resmed (NYSE:RMD) announced today that it entered into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results